BD (Becton, Dickinson and Company), a leading global medical technology company, has started to ship the first over-the-counter (OTC) Covid-19 rapid antigen test to use computer vision technology in a ...
BD (Becton, Dickinson and Company) (NYSE: BDX) has announced its rapid, point-of-care, SARS-CoV-2 antigen test for use on the BD Veritorâ„¢ Plus System has been CE marked to the IVD Directive (98/79/EC) ...
FRANKLIN LAKES, N.J., Sept. 9, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the results of a new research study ...